A Pilot Study of Terazosin for Parkinson's Disease
Phase 1
Completed
- Conditions
- Parkinson Disease
- Interventions
- Drug: Placebo oral capsule
- First Posted Date
- 2019-04-05
- Last Posted Date
- 2022-05-16
- Lead Sponsor
- Jordan Schultz
- Target Recruit Count
- 13
- Registration Number
- NCT03905811
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
Active, not recruiting
- Conditions
- Huntington Disease
- First Posted Date
- 2003-01-09
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Jordan Schultz
- Target Recruit Count
- 1700
- Registration Number
- NCT00051324
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
© Copyright 2025. All Rights Reserved by MedPath